Analytical Data
-
Gene name
GNg2
- Application
-
Alternative Names
GNg2；Guanine nucleotide-binding Protein G(I)/G(S)/G(T) subunit beta-1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P59768
-
Expression Region
2-68aa
-
AA Sequence
ASNNTASIA QARKLVEQLK MEANIDRIKV SKAAADLMAY CEAHAKEDPL LTPVPASENP FREKKFFC
-
Molecular Weight
7.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GNg2 recombinant protein research focuses on the GNg2 protein, a member of the guanine nucleotide-binding (G) protein family, which plays a critical role in various cellular processes, including signal transduction, cellular communication, and regulation of metabolic pathways. This protein is involved in the activation of second messengers, which mediate a wide range of physiological responses. The study of GNg2 is important for understanding its function in health and disease, as dysregulation of G protein signaling has been linked to various conditions, including cancer, cardiovascular diseases, and neurological disorders. The recombinant expression of GNg2 allows for in-depth biochemical and biophysical characterization, enabling scientists to explore its interactions with receptors, downstream effectors, and other signaling molecules. Furthermore, GNg2's potential as a therapeutic target makes it a significant focus of research aimed at developing novel treatments that can modulate G protein signaling pathways. By generating GNg2 in a recombinant form, researchers can assess its functional properties, screen for small-molecule modulators, and investigate the structural basis of its activity, all of which contribute to a better understanding of G protein-coupled receptor signaling dynamics in health and disease.
